§ 13F · FUND PROFILE
SPHERA FUNDS MANAGEMENT LTD..
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 97Turnover · — · Q1Filed · May 15, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$91M deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q1 2026
FILED MAY 15, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q1 |
|---|---|---|---|---|---|---|
| 1 | MLYS | MINERALYS THERAPEUTICS INC | 1.34M | $36M | 5.8% | +198% |
| 2 | TEVA | TEVA PHARMACEUTICAL INDS LTD | 1.05M | $32M | 5.0% | +1% |
| 3 | TSEM | TOWER SEMICONDUCTOR LTD | 146K | $26M | 4.1% | +19% |
| 4 | XBI | SPDR SERIES TRUST | 200K | $26M | 4.1% | +186% |
| 5 | NVMI | NOVA LTD | 53K | $23M | 3.7% | +12% |
| 6 | BBIO | BRIDGEBIO PHARMA INC | 245K | $18M | 2.9% | +128% |
| 7 | CYTK | CYTOKINETICS INC | 259K | $17M | 2.7% | +226% |
| 8 | BIIB | BIOGEN INC | 93K | $17M | 2.7% | −2% |
| 9 | RARE | ULTRAGENYX PHARMACEUTICAL IN | 809K | $17M | 2.7% | +24% |
| 10 | SNDX | SYNDAX PHARMACEUTICALS INC | 725K | $17M | 2.7% | −5% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE SPHERA SIGNAL
AC read
SPHERA FUNDS MANAGEMENT LTD. is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q1 2026
Steady book
+0 buys · −0 exits · 0 changed
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed